









Markets
/
Stocks
/
nasdaq-lsb
/

LakeShore Biopharma Co Ltd

LSB

View Detailed Chart

0.730USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

13.93MMarket Cap

--P/E TTM



LakeShore Biopharma Co Ltd

0.730

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

-10.12%

5 Days

-36.52%

1 Month

-26.64%

6 Months

-69.07%

Year to Date

-78.90%

1 Year

-83.84%

View Detailed Chart

Agency Rating

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(9)

Neutral(1)

Buy(0)

Indicators

Sell(3)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.092

Sell

RSI(14)

36.240

Neutral

STOCH(KDJ)(9,3,3)

7.247

Oversold

ATR(14)

0.151

High Vlolatility

CCI(14)

-163.698

Sell

Williams %R

96.094

Oversold

TRIX(12,20)

-0.265

Sell

StochRSI(14)

9.133

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

0.828

Sell

MA10

1.009

Sell

MA20

1.061

Sell

MA50

1.032

Sell

MA100

1.363

Sell

MA200

2.026

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.

Ticker SymbolLSB

CompanyLakeShore Biopharma Co Ltd

CEOMr. Dave Chenn

Website